Discovery of potent adenosine A2a antagonists as potential anti-Parkinson disease agents. Non-linear QSAR analyses integrated with pharmacophore modeling

Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships

David Rogers, A. J. Hopfinger · Journal of Chemical Information and Computer Sciences · 1994 · 982 citations

Natural Sciences, Chemistry, Computational Chemistry +14

Novel Variable Selection Quantitative Structure−Property Relationship Approach Based on the<i>k</i>-Nearest-Neighbor Principle

Weifan Zheng, Alexander Tropsha · Journal of Chemical Information and Computer Sciences · 1999 · 451 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Virtual Screening Using Protein−Ligand Docking:  Avoiding Artificial Enrichment

Marcel L. Verdonk, Valério Berdini, Michael J. Hartshorn et al. · Journal of Chemical Information and Computer Sciences · 2004 · 378 citations

Pharmacy, Medicinal Chemistry, Computational Medicinal Chemistry +14

Adenosine A _2A receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005)

Peter A. LeWitt, Mark Guttman, James W. Tetrud et al. · Annals of Neurology · 2008 · 350 citations

Medicine, Neurology, Pharmacology +13

Potent, selective, and orally active adenosine A2A receptor antagonists: Arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines

Bernard R. Neustadt, Jinsong Hao, Neil Lindo et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 137 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13